Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank69
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-2.26%
↑ 100% vs avg
Percentile
P69
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-942.12%
Historical baseline
PeriodValueYoY Change
TTM-2.26%+94.8%
2024-43.33%-62.4%
2023-26.68%+17.2%
2022-32.22%+75.8%
2021-133.25%-2.0%
2020-130.61%-56.5%
2019-83.48%-0.9%
2018-82.75%-91.5%
2017-43.21%+99.5%
2016-8843.45%-